NCT05969704Completed
Fusion Versus Cognitive MRI Targeted Prostatic Biopsy
Magnetic Resonance Imaging Targeted (fusion) Versus Cognitive Prostatic Biopsy in Biopsy-naïve Suspected Cancer Prostate Patient a Comparison Study
Source: ClinicalTrials.gov · Last updated 23 Jan 2025
Brief summary (registry, in English)
The aim of the present study is to compare the accuracy of Magnetic resonance imaging targeted (fusion) versus cognitive prostatic biopsy in biopsy-naïve suspected cancer prostate patient
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 130 (actual)
- First submitted
- 23 Jul 2023
- Start date
- 1 Jan 2023
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Menoufia University
- Diseases
- Prostate cancer, Childhood cancers
- NCT number
- NCT05969704
What you commit to
- Study type: Interventional
- Participants enrolled: 130
- From 1 Jan 2023 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- patient with history of TRUS biopsy
- patient diagnosed as cancer prostate or with distant metastasis
Other
- PSA level greater than 20 ng/mL
Who the study is looking for
- prostate biopsy-naïve men
- PSA levels of up to 20 ng/mL
- Multi-parametric prostate MRI revealed a PIRAD 4 or PIRAD 5.
Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Menoufia University Hospital Coordinator of this site? Confirm its status | Shibīn al Kawm | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.